Novoprotein Scientific Inc. (SHA:688137)

Novoprotein Scientific Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	773.9	647.35	863.7	929.92	189.39	68.68
Short-Term Investments	990.45	1,154	404.51	-	-	-
Trading Asset Securities	-	-	621.7	966.85	-	25.14
Cash & Short-Term Investments	1,764	1,801	1,890	1,897	189.39	93.83
Cash Growth	-6.62%	-4.69%	-0.36%	901.50%	101.86%	2063.73%
Accounts Receivable	71.09	62.02	79.97	134.66	96.58	23.03
Other Receivables	11.55	10.91	3.45	10.35	2.95	7.53
Receivables	82.64	72.93	83.42	145	99.53	30.56
Inventory	66.17	76.08	84.97	77.08	37.19	18.71
Other Current Assets	6.26	5.95	11.9	16.29	6.11	2.37
Total Current Assets	1,919	1,956	2,070	2,135	332.22	145.47
Property, Plant & Equipment	195.88	170.14	133.92	134.98	137.95	12.77
Long-Term Investments	10	10	-	-	-	-
Other Intangible Assets	18.03	18.21	18.71	18.18	6.71	0.11
Long-Term Deferred Tax Assets	35.85	31.22	27.94	18.51	12.96	10.7
Long-Term Deferred Charges	9.52	10.78	9.69	5.6	4.93	2.62
Other Long-Term Assets	9.81	21.48	38.45	21.05	18.33	0.27
Total Assets	2,198	2,218	2,299	2,333	513.1	171.93
Accounts Payable	13.1	28.26	17.94	20.9	23.64	8.22
Accrued Expenses	13.59	14.82	11.82	18.03	21.21	18.92
Current Portion of Leases	13.64	17.67	13.87	13.95	8.69	-
Current Income Taxes Payable	0	0.01	1.34	5.01	4.52	15.55
Current Unearned Revenue	5.13	5.02	4.19	4.81	11.61	13.24
Other Current Liabilities	28.56	1.39	0.97	1.32	2.11	11.4
Total Current Liabilities	74.02	67.17	50.12	64.02	71.78	67.33
Long-Term Leases	41.18	48.75	59.44	69.2	78.34	-
Long-Term Unearned Revenue	1.24	0.52	0.87	-	-	-
Long-Term Deferred Tax Liabilities	-	-	-	-	3.21	1.51
Total Liabilities	116.44	116.44	110.43	133.22	153.33	68.83
Common Stock	70.18	70.18	70.18	70.18	52.63	15.88
Additional Paid-In Capital	1,970	1,963	1,950	1,940	208.13	31.51
Retained Earnings	54.13	78.36	167.86	190.1	98.82	55.51
Treasury Stock	-11.96	-10.35	-	-	-	-
Comprehensive Income & Other	0.17	0.15	0.18	0.18	0.19	0.2
Shareholders' Equity	2,082	2,102	2,188	2,200	359.77	103.1
Total Liabilities & Equity	2,198	2,218	2,299	2,333	513.1	171.93
Total Debt	54.81	66.42	73.31	83.15	87.04	-
Net Cash (Debt)	1,710	1,735	1,817	1,814	102.36	93.83
Net Cash Growth	-5.60%	-4.50%	0.16%	1671.86%	9.09%	28293.51%
Net Cash Per Share	24.38	24.87	25.46	31.79	2.56	5.91
Filing Date Shares Outstanding	69.77	69.83	70.18	70.18	52.63	15.88
Total Common Shares Outstanding	69.77	69.83	70.18	70.18	52.63	15.88
Working Capital	1,845	1,889	2,020	2,071	260.44	78.14
Book Value Per Share	29.84	30.10	31.19	31.35	6.84	6.49
Tangible Book Value	2,064	2,083	2,170	2,182	353.06	102.99
Tangible Book Value Per Share	29.58	29.84	30.92	31.09	6.71	6.48
Machinery	81.27	78.93	64.44	59.66	42.2	21.33
Construction In Progress	116.48	74.95	31.26	17.73	21.16	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.